Cargando…

Effects of light fractionation and different fluence rates on photodynamic therapy with 5-aminolaevulinic acid in vivo

To improve efficacy of photodynamic therapy (PDT) with intravenously administered 5-aminolaevulinic acid (ALA) fractionating the light dose or reducing the light intensity may be a possibility. Therefore, Syrian Golden hamsters were fitted with dorsal skinfold chambers containing an amelanotic melan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Babilas, P, Schacht, V, Liebsch, G, Wolfbeis, O S, Landthaler, M, Szeimies, R-M, Abels, C
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2003
Materias:	Experimental Therapeutics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2741044/ https://www.ncbi.nlm.nih.gov/pubmed/12778078 http://dx.doi.org/10.1038/sj.bjc.6600910

Ejemplares similares

Aminolaevulinic acid-induced photodynamic therapy: cellular responses to glucose starvation
por: Wyld, L, et al.
Publicado: (2002)

Enhanced effects of aminolaevulinic acid-based photodynamic therapy through local hyperthermia in rat tumours
por: Kelleher, D K, et al.
Publicado: (2003)

The role of reperfusion injury in photodynamic therapy with 5-aminolaevulinic acid – a study on normal rat colon
por: Curnow, A, et al.
Publicado: (2002)

Methotrexate used in combination with aminolaevulinic acid for photodynamic killing of prostate cancer cells
por: Sinha, A K, et al.
Publicado: (2006)

Porphyrin accumulation induced by 5-aminolaevulinic acid esters in tumour cells growing in vitro and in vivo
por: Tunstall, R G, et al.
Publicado: (2002)

Influence of a haematoporphyrin derivative on the protoporphyrin IX synthesis and photodynamic effect after 5-aminolaevulinic acid sensitization in human colon carcinoma cells.
por: Messmann, H., et al.
Publicado: (1997)

Photodynamic therapy effect of m-THPC (Foscan®) in vivo: correlation with pharmacokinetics
por: Jones, H J, et al.
Publicado: (2003)

Porphyrin synthesis from ALA derivatives for photodynamic therapy. In vitro and in vivo studies
por: Perotti, C, et al.
Publicado: (2004)

Protoporphyrin IX enhancement by 5-aminolaevulinic acid peptide derivatives and the effect of RNA silencing on intracellular metabolism
por: Bourré, L, et al.
Publicado: (2009)

Comparing desferrioxamine and light fractionation enhancement of ALA-PpIX photodynamic therapy in skin cancer
por: de Souza, Ana Luiza Ribeiro, et al.
Publicado: (2016)

Photo-oxidative killing of human colonic cancer cells using indocyanine green and infrared light
por: Bäumler, W, et al.
Publicado: (1999)

Indocyanine green and laser light for the treatment of AIDS-associated cutaneous Kaposi's sarcoma.
por: Abels, C., et al.
Publicado: (1998)

In vivo kinetics and spectra of 5-aminolaevulinic acid-induced fluorescence in an amelanotic melanoma of the hamster.
por: Abels, C., et al.
Publicado: (1994)

Enhancement of photodynamic therapy with 5-aminolaevulinic acid-induced porphyrin photosensitisation in normal rat colon by threshold and light fractionation studies.
por: Messmann, H., et al.
Publicado: (1995)

Reduction of tumour oxygenation during and after photodynamic therapy in vivo: effects of fluence rate.
por: Sitnik, T. M., et al.
Publicado: (1998)

Efficacy of intravenous delta-aminolaevulinic acid photodynamic therapy on rabbit papillomas.
por: Lofgren, L. A., et al.
Publicado: (1995)

Foscan® uptake and tissue distribution in relation to photodynamic efficacy
por: Cramers, P, et al.
Publicado: (2003)

The effect of aminolaevulinic acid-induced, protoporphyrin IX-mediated photodynamic therapy on the cremaster muscle microcirculation in vivo.
por: Leveckis, J., et al.
Publicado: (1995)

Methyl Aminolaevulinic Acid versus Aminolaevulinic Acid Photodynamic Therapy of Actinic Keratosis with Low Doses of Red-Light LED Illumination: Results of Long-Term Follow-Up
por: Fernández Guarino, Montserrat, et al.
Publicado: (2022)

Ischaemia-reperfusion injury in photodynamic therapy-treated mouse tumours
por: Korbelik, M, et al.
Publicado: (2003)

Pegylation of charged polymer-photosensitiser conjugates: effects on photodynamic efficacy
por: Hamblin, M R, et al.
Publicado: (2003)

Oral versus intravenous administration of 5-aminolaevulinic acid for photodynamic therapy.
por: Loh, C. S., et al.
Publicado: (1993)

Bax is essential for mitochondrion-mediated apoptosis but not for cell death caused by photodynamic therapy
por: Chiu, S-M, et al.
Publicado: (2003)

Role of cytokines in photodynamic therapy-induced local and systemic inflammation
por: Gollnick, S O, et al.
Publicado: (2003)

Selective accumulation of ALA-induced PpIX and photodynamic effect in chemically induced hepatocellular carcinoma
por: Otake, M, et al.
Publicado: (2003)

Photodynamic diagnosis of ovarian cancer using hexaminolaevulinate: a preclinical study
por: Lüdicke, F, et al.
Publicado: (2003)

In-Vivo Optical Monitoring of the Efficacy of Epidermal Growth Factor Receptor Targeted Photodynamic Therapy: The Effect of Fluence Rate
por: Peng, Wei, et al.
Publicado: (2020)

Combined hyperthermia and chlorophyll-based photodynamic therapy: tumour growth and metabolic microenvironment
por: Kelleher, D K, et al.
Publicado: (2003)

Differentiation-dependent photodynamic therapy regulated by porphobilinogen deaminase in B16 melanoma
por: Ickowicz Schwartz, D, et al.
Publicado: (2004)

5-Aminolaevulinic Acid-Based Photodynamic Therapy Restrains Pathological Hyperplasia of Fibroblasts
por: Wang, Xiaochuan, et al.
Publicado: (2017)

Photodynamic detection of a feline meningioma using 5-aminolaevulinic acid hydrochloride
por: Osaki, Tomohiro, et al.
Publicado: (2020)

Differentiation enhances aminolevulinic acid-dependent photodynamic treatment of LNCaP prostate cancer cells
por: Ortel, B, et al.
Publicado: (2002)

Selectivity of the photosensitiser Tookad® for photodynamic therapy evaluated in the Syrian golden hamster cheek pouch tumour model
por: Borle, F, et al.
Publicado: (2003)

In vivo fluorescence kinetics and photodynamic therapy using 5-aminolaevulinic acid-induced porphyrin: increased damage after multiple irradiations.
por: van der Veen, N., et al.
Publicado: (1994)

Comparing efficacy of reduced-fluence and standard-fluence photodynamic therapy in the treatment of polypoidal choroidal vasculopathy
por: Ngo, Wei Kiong, et al.
Publicado: (2020)

Superficial photodynamic therapy with topical 5-aminolaevulinic acid for superficial primary and secondary skin cancer.
por: Cairnduff, F., et al.
Publicado: (1994)

In vitro studies on the potential use of 5-aminolaevulinic acid-mediated photodynamic therapy for gynaecological tumours.
por: Rossi, F. M., et al.
Publicado: (1996)

Correlation of real-time haemoglobin oxygen saturation monitoring during photodynamic therapy with microvascular effects and tissue necrosis in normal rat liver
por: Woodhams, J H, et al.
Publicado: (2004)

Photodynamic therapy using 5-aminolaevulinic acid for experimental pancreatic cancer--prolonged animal survival.
por: Regula, J., et al.
Publicado: (1994)

Dermoscopic Monitoring for Treatment and Follow-Up of Actinic Keratosis With 5-Aminolaevulinic Acid Photodynamic Therapy
por: Xiaoqin, Yang, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_9h0do98i54pl8q8lpfu2433jg4